IPP Bureau
Roche wins CE mark for blood-based MS brain damage test
By IPP Bureau - April 14, 2026
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
Aster DM Healthcare invests Rs 96 crore to add 159-bed specialised Aster Women & Children centre in Bengaluru
By IPP Bureau - April 14, 2026
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial
By IPP Bureau - April 14, 2026
Highlights Mirvetuximab-based regimen promise
Apollo Hospitals Navi Mumbai launches dedicated paediatric rehabilitation centre
By IPP Bureau - April 14, 2026
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
Max Institute of Cancer Care, Vaishali showcases advanced oncology technologies at ONCO-CON 2026
By IPP Bureau - April 14, 2026
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
Sun Pharma unveils new brand film highlighting shared ‘No. 1’ spirit with Royal Challengers Bengaluru
By IPP Bureau - April 14, 2026
The campaign builds on the three-year partnership unveiled earlier this season
Happiest Health expands dental care footprint with its second Happiest Pearls Clinic
By IPP Bureau - April 14, 2026
Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model
Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit
By IPP Bureau - April 14, 2026
The license is valid for five years, effective from April 9, 2026
Pharma firms accelerate regional GLP-1 capacity to de-risk supply chains amid geopolitical tensions: GlobalData
By IPP Bureau - April 14, 2026
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role
By IPP Bureau - April 13, 2026
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Unichem’s US arm recalls Buspirone tablets after stability test OOS result
By IPP Bureau - April 13, 2026
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
Ankura Hospitals strengthens pediatric center of excellence as complex child cases rise
By IPP Bureau - April 13, 2026
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
SRMIST to host global physiotherapy and hand rehabilitation conclave on 16-18 April
By IPP Bureau - April 13, 2026
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
Merck India, MAHE launch catalyst program to build future R&D talent pipeline
By IPP Bureau - April 13, 2026
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap
By IPP Bureau - April 13, 2026
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
